<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">akusherstvo</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics, Gynecology and Reproduction</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство, Гинекология и Репродукция</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7347</issn><issn pub-type="epub">2500-3194</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2313-7347/ob.gyn.rep.2023.464</article-id><article-id custom-type="elpub" pub-id-type="custom">akusherstvo-1866</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group></article-categories><title-group><article-title>Endometrial hyperplastic processes: modern approaches to diagnosis and treatment</article-title><trans-title-group xml:lang="ru"><trans-title>Гиперпластические процессы эндометрия: современные подходы к диагностике и лечению</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3175-4847</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Свиридова</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sviridova</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Свиридова Наталия Ивановна – д.м.н., доцент, зав. кафедрой акушерства и гинекологии Института непрерывного медицинского и фармацевтического образования</p><p>400131 Волгоград, площадь Павших Борцов, д. 1</p></bio><bio xml:lang="en"><p>Natalia I. Sviridova – MD, Dr Sci Med, Associate Professor, Head of the Department of Obstetrics and Gynecology, Institute of Continuing Medical and Pharmaceutical Education</p><p>1 Pavshikh Bortsov Square, Volgograd 400131</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1935-4277</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ткаченко</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tkachenko</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ткаченко Людмила Владимировна – д.м.н., профессор, профессор кафедры акушерства и гинекологии Института непрерывного медицинского и фармацевтического образования</p><p>400131 Волгоград, площадь Павших Борцов, д. 1</p></bio><bio xml:lang="en"><p>Lyudmila V. Tkachenko – MD, Dr Sci Med, Professor, Department of Obstetrics and Gynecology, Institute of Continuing Medical and Pharmaceutical Education</p><p>1 Pavshikh Bortsov Square, Volgograd 400131</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9422-0623</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яхонтова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Yakhontova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Яхонтова Мария Александровна – к.м.н., доцент кафедры акушерства и гинекологии Института непрерывного медицинского и фармацевтического образования</p><p>400131 Волгоград, площадь Павших Борцов, д. 1</p></bio><bio xml:lang="en"><p>Mariya A. Yakhontova – MD, PhD, Associate Professor, Department of Obstetrics and Gynecology, Institute of Continuing Medical and Pharmaceutical Education</p><p>1 Pavshikh Bortsov Square, Volgograd 400131</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6761-2990</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гриценко</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gritsenko</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гриценко Ирина Анатольевна – к.м.н., доцент кафедры акушерства и гинекологии Института непрерывного медицинского и фармацевтического образования</p><p>400131 Волгоград, площадь Павших Борцов, д. 1</p></bio><bio xml:lang="en"><p>Irina A. Gritsenko – MD, PhD, Associate Professor, Department of Obstetrics and Gynecology, Institute of Continuing Medical and Pharmaceutical Education</p><p>1 Pavshikh Bortsov Square, Volgograd 400131</p></bio><email xlink:type="simple">irina-gritsenko@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5838-1385</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Максимов</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Maximov</surname><given-names>S. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Максимов Сергей Николаевич – аспирант кафедры акушерства и гинекологии Института непрерывного медицинского и фармацевтического образования</p><p>400131 Волгоград, площадь Павших Борцов, д. 1</p></bio><bio xml:lang="en"><p>Sergey N. Maximov – MD, Postgraduate Student, Department of Obstetrics and Gynecology, Institute of Continuing Medical and Pharmaceutical Education</p><p>1 Pavshikh Bortsov Square, Volgograd 400131</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2915-6132</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пурясева</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Puryaseva</surname><given-names>K. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пурясева Ксения Анатольевна – аспирант кафедры акушерства и гинекологии Института непрерывного медицинского и фармацевтического образования</p><p>400131 Волгоград, площадь Павших Борцов, д. 1</p></bio><bio xml:lang="en"><p>Kseniya A. Puryaseva – MD, Postgraduate Student, Department of Obstetrics and Gynecology, Institute of Continuing Medical and Pharmaceutical Education</p><p>1 Pavshikh Bortsov Square, Volgograd 400131</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Волгоградский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Volgograd State Medical University, Health Ministry of Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>25</day><month>12</month><year>2023</year></pub-date><volume>18</volume><issue>1</issue><fpage>83</fpage><lpage>95</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Sviridova N.I., Tkachenko L.V., Yakhontova M.A., Gritsenko I.A., Maximov S.N., Puryaseva K.A., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Свиридова Н.И., Ткаченко Л.В., Яхонтова М.А., Гриценко И.А., Максимов С.Н., Пурясева К.А.</copyright-holder><copyright-holder xml:lang="en">Sviridova N.I., Tkachenko L.V., Yakhontova M.A., Gritsenko I.A., Maximov S.N., Puryaseva K.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gynecology.su/jour/article/view/1866">https://www.gynecology.su/jour/article/view/1866</self-uri><abstract><p>An issue of endometrial hyperplastic processes in the reproductive period is one of the pressing problems of gynecology due to their high prevalence in this age group. The continuing interest in this issue is determined by the data that endometrial hyperplastic processes tend to have a long, relapsing course, the lack of specific, pathognomonic symptoms as well as the complexity in differential diagnosis and choice of methods for prevention and treatment. Unfortunately, the problem of treating such patients remains far from being solved, which dictates a need to optimize patient management tactics, which should be aimed not only at creating proper integrated approaches to predicting development and recurrence of endometrial hyperplastic processes, but also developing a differentiated approach to management patients with this pathology in order to reduce gynecological and oncological morbidity as well as increase reproductive potential in this patient cohort.</p></abstract><trans-abstract xml:lang="ru"><p>Проблема гиперпластических процессов эндометрия в репродуктивном периоде является одной из актуальных проблем гинекологии в связи с высокой распространенностью этой патологии у женщин данного возраста. Неослабевающий интерес к ней определяется их тенденцией к длительному, рецидивирующему течению, отсутствием специфических, патогномоничных симптомов, а также сложностью дифференциальной диагностики и выбора методов профилактики и лечения. К сожалению, проблема лечения больных с данной патологией до настоящего времени остается далекой от своего решения, что диктует необходимость оптимизации тактики ведения пациенток, которая должна быть направлена не только на создание адекватных комплексных подходов прогнозирования развития и рецидивирования гиперпластических процессов эндометрия, но и разработку дифференцированного подхода к ведению больных с этой патологией с целью снижения гинекологической и онкологической заболеваемости, а также повышения репродуктивного потенциала данной когорты пациенток.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гиперплазия эндометрия</kwd><kwd>полипы эндометрия</kwd><kwd>факторы риска</kwd><kwd>противорецидивная терапия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>endometrial hyperplasia</kwd><kwd>endometrial polyps</kwd><kwd>risk factors</kwd><kwd>anti-relapse therapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Думановская М.Р., Чернуха Г.Е., Табеева Г.И., Асатурова А.В. Гиперплазия эндометрия: поиск оптимальных решений и стратегий. Акушерство и гинекология. 2021;(4):23–31.https://doi.org/10.18565/aig.2021.4.23-31.</mixed-citation><mixed-citation xml:lang="en">Dumanovskaya M.R., Chernukha G.E., Tabeeva G.I., Asaturova A.V. Endometrial hyperplasia: search for optimal solutions and strategies. [Giperplaziya endometriya: poisk optimal'nyh reshenij i strategij].  Akusherstvo  i  ginekologiya.  2021;(4):23–31.  (In  Russ.). https://doi.org/10.18565/aig.2021.4.23-31.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Подзолкова Н.М., Коренная В.В. Современные представления об этиологии, патогенезе и принципах лечения гиперплазии эндометрия. Акушерство и гинекология. 2021;(8):192–9. https://doi.org/10.18565/aig.2021.8.192-199.</mixed-citation><mixed-citation xml:lang="en">Podzolkova N.M., Korennaya V.V. Modern ideas about the etiology, pathogenesis and principles of treatment of endometrial hyperplasia. [Sovremennye predstavleniya ob etiologii, patogeneze i principah lecheniya giperplazii endometriya]. Akusherstvo i ginekologiya. 2021;(8):192–9. (In Russ.). https://doi.org/10.18565/aig.2021.8.192-199.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации. Гиперплазия эндометрия. M.: Министерство здравоохранения Российской Федерации, 2021. 45 с. Режим доступа: https://www.rzn8gb.ru/pub/att/9_1344_482.pdf. [Дата обращения: 10.11.2023].</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines. Endometrial hyperplasia. [Klinicheskie rekomendacii. Giperplaziya endometriya]. Moscow: Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2021. 45 p. (In Russ.). Available at: https://www.rzn8gb.ru/pub/att/9_1344_482.pdf. [Accessed: 10.11.2023].</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Габидуллина Р.И., Смирнова Г.А., Нухбала Ф.Р. и др. Гиперпластические процессы эндометрия: современная тактика ведения пациенток. Гинекология. 2019;21(6):53–8. https://doi.org/10.26442/20795696.2019.6.190472.</mixed-citation><mixed-citation xml:lang="en">Gabidullina R.I., Smirnova G.A., Nuhbala F.R. et al. Hyperplastic processes of the endometrium: modern tactics of patient management. [Giperplasticheskie process endometriya: sovremennaya taktika  vedeniya  pacientok].  Ginekologiya.  2019;21(6):53–8.  (In  Russ.). https://doi.org/10.26442/20795696.2019.6.190472.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Багдасарян Л.Ю., Пономарев В.В., Карахалис Л.Ю. и др. Факторы, влияющие на развитие полипов эндометрия. Кубанский научный медицинский вестник. 2018;25(2):25–8. https://doi.org/10.25207/1608-6228-2018-25-2-25-28.</mixed-citation><mixed-citation xml:lang="en">Bagdasaryan L.Yu., Ponomarev V.V., Karakhalis L.Yu. et al. Factors influencing the development of endometrial polyps. [Faktory, vliyayushchie na razvitie polipov endometriya]. Kubanskij  nauchnyj  medicinskij  vestnik.  2018;25(2):25–8.  (In  Russ.). https://doi.org/10.25207/1608-6228-2018-25-2-25-28.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Andrews W.W., Hauth J.C., Cliver S.P. et al. Association of asymptomatic bacterial vaginosis with endometrial microbial colonization and plasma cell endometritis in nonpregnant women. Am J Obstet Gynecol. 2006;195(6):1611–6. https://doi.org/10.1016/j.ajog.2006.04.010.</mixed-citation><mixed-citation xml:lang="en">Andrews W.W., Hauth J.C., Cliver S.P. et al. Association of asymptomatic bacterial vaginosis with endometrial microbial colonization and plasma cell endometritis in nonpregnant women. Am J Obstet Gynecol. 2006;195(6):1611–6. https://doi.org/10.1016/j.ajog.2006.04.010.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">De Marchi F., Fabris A.M., Tommasi L. et al. Accuracy of hysteroscopy made by young residents in detecting endometrial pathologies in postmenopausal women. Eur J Gynaecol Oncol. 2014;35(3):219–23.</mixed-citation><mixed-citation xml:lang="en">De Marchi F., Fabris A.M., Tommasi L. et al. Accuracy of hysteroscopy made by young residents in detecting endometrial pathologies in postmenopausal women. Eur J Gynaecol Oncol. 2014;35(3):219–23.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Асатурова А.В., Чернуха Г.Е., Иванов И.А., Куземин А.А. Клинико-морфометрические особенности полипов эндометрия и механизмы возникновения аномальных маточных кровотечений. Акушерство и гинекология. 2019;(7):64–70. https://doi.org/10.18565/aig.2019.7.64-70.</mixed-citation><mixed-citation xml:lang="en">Asaturova A.V., Chernukha G.E., Ivanov I.A., Kuzemin A.A. Clinical and morphometric characteristics features of endometrial polyps and underlying mechanisms of abnormal uterine bleeding.  [Kliniko-morfometricheskie  osobennosti  polipov  endometriya  i  mekhanizmy vozniknoveniya anomal'nyh matochnyh krovotechenij]. Akusherstvo i ginekologiya. 2019;(7):64–70. (In Russ.). https://doi.org/10.18565/aig.2019.7.64-70.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Clevenger-Hoeft M., Syrop C.H., Stovall D.W., Van Voorhis B.J. Sonohysterography in premenopausal women with and with-out abnormal bleeding. Obstet Gynecol. 1999;94(4):516–20. https://doi.org/10.1016/s0029-7844(99)00345-2.</mixed-citation><mixed-citation xml:lang="en">Clevenger-Hoeft M., Syrop C.H., Stovall D.W., Van Voorhis B.J. Sonohysterography in premenopausal women with and with-out abnormal bleeding. Obstet Gynecol. 1999;94(4):516–20. https://doi.org/10.1016/s0029-7844(99)00345-2.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Clark T.J., Stevenson H. Endometrial polyps and abnormal uterine bleeding (AUB-P): what is the relationship, how are they diagnosed and how are they treated? Best Pract Res Clin Obstet Gynaecol. 2017;40:89–104.https://doi.org/10.1016/j.bpobgyn.2016.09.005.</mixed-citation><mixed-citation xml:lang="en">Clark T.J., Stevenson H. Endometrial polyps and abnormal uterine bleeding (AUB-P): what is the relationship, how are they diagnosed and how are they treated? Best Pract Res Clin Obstet Gynaecol. 2017;40:89–104.https://doi.org/10.1016/j.bpobgyn.2016.09.005.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen M.A., Sauer M.V., Keltz M., Lindheim R. Utilizing routine sonohysterography to detect intrauterine pathology before initiating hormone replacement therapy. Menopause. 1999;6(1):68–70.</mixed-citation><mixed-citation xml:lang="en">Cohen M.A., Sauer M.V., Keltz M., Lindheim R. Utilizing routine sonohysterography to detect intrauterine pathology before initiating hormone replacement therapy. Menopause. 1999;6(1):68–70.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Cakmak H., Taylor H.S. Implantation failure: molecular mechanisms and clinical treatment. Hum Reprod Update. 2011;17(2):242–53. https://doi.org/10.1093.humupd/dmq037.</mixed-citation><mixed-citation xml:lang="en">Cakmak H., Taylor H.S. Implantation failure: molecular mechanisms and clinical treatment. Hum Reprod Update. 2011;17(2):242–53. https://doi.org/10.1093.humupd/dmq037.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Tanos V., Berry K.E., Seikkula J. et al. The management of polyps in femalereproductiveorgans. Int J Surg. 2017;43:7–16. https://doi.org/10.1016/j.ijsu.2017.05.012.</mixed-citation><mixed-citation xml:lang="en">Tanos  V.,  Berry  K.E.,  Seikkula  J.  et  al.  The  management  of  polyps  in femalereproductiveorgans. Int J Surg. 2017;43:7–16. https://doi.org/10.1016/j.ijsu.2017.05.012.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Capmas P., Pourcelot A.G., Giral E. et al. Office hysteroscopy: a report of 2402 cases. J Gynecol Obstet Biol Reprod (Paris). 2016;45(5):445–50. https://doi.org/10.1016/j.jgyn.2016.02.007</mixed-citation><mixed-citation xml:lang="en">Capmas P., Pourcelot A.G., Giral E. et al. Office hysteroscopy: a report of 2402 cases. J Gynecol Obstet Biol Reprod (Paris). 2016;45(5):445–50. https://doi.org/10.1016/j.jgyn.2016.02.007</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Чернуха Г.Е., Асатурова А.В., Иванов И.А., Думановская М.Р. Структура патологии эндометрия в различные возрастные периоды. Акушерство и гинекология. 2018;(8):129–34. https://doi.org/10.18565/aig.2018.8.129-134.</mixed-citation><mixed-citation xml:lang="en">Chernukha G.E., Asaturova A.V., Ivanov I.A., Dumanovskaya M.R. Endometrial lesion’s pattern in different age groups. [Struktura patologii endometriya v razlichnye vozrastnye periody]. Akusherstvo i ginekologiya. 2018;(8):129–34. (In Russ.). https://doi.org/10.18565/aig.2018.8.129-134.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Саттаров Ш.Н., Коган Е.А., Саркисов С.Э. и др. Молекулярные механизмы патогенеза полипов эндометрия в постменопаузе. Акушерство и гинекология. 2013;(6):17–22.</mixed-citation><mixed-citation xml:lang="en">Sattarov Sh.N., Kogan E.A., Sarkisov S.E. et al. Molecular mechanisms of the pathogenesis of postmenopausal endometrial polyps. [Molekulyarnye mekhanizmy patogeneza polipov endometriya v postmenopauze]. Akusherstvo i ginekologiya. 2013;(6):17–22. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Xuebing P., TinChiu L., Enlan X. et al. Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Eur J Obstet Gynecol Reprod Biol. 2011;159(1):198–203. https://doi.org/10.1016/j.ejogrb.2011.06.036.</mixed-citation><mixed-citation xml:lang="en">Xuebing P., TinChiu L., Enlan X. et al. Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Eur  J  Obstet  Gynecol  Reprod  Biol.  2011;159(1):198–203. https://doi.org/10.1016/j.ejogrb.2011.06.036.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gentry-Maharaj A., Karpinskyj C. Current and future approaches to screening for endometrial cancer. Best Pract Res Clin Obstet Gynaecol. 2020;65:79–97. https://doi.org/10.1016/j.bpobgyn.2019.12.006.</mixed-citation><mixed-citation xml:lang="en">Gentry-Maharaj A., Karpinskyj C. Current and future approaches to screening for endometrial cancer.  Best  Pract  Res  Clin  Obstet  Gynaecol.  2020;65:79–97. https://doi.org/10.1016/j.bpobgyn.2019.12.006.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Clarke M.A., Long B.J., Del Mar Morillo A. et al. Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis. JAMA Int Med. 2018;178(9):1210–22. https://doi.org/10.1001/jamainternmed.2018.2820.</mixed-citation><mixed-citation xml:lang="en">Clarke M.A., Long B.J., Del Mar Morillo A. et al. Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis. JAMA Int Med. 2018;178(9):1210–22. https://doi.org/10.1001/jamainternmed.2018.2820.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Parazzini F., Viganò P., Candiani M., Fedele L. Diet and endometriosis risk: a literature review. Reprod Biomed Online. 2013;26(4):323–36. https://doi.org/10.1016/j.rbmo.2012.12.011.</mixed-citation><mixed-citation xml:lang="en">Parazzini F., Viganò P., Candiani M., Fedele L. Diet and endometriosis risk: a literature review. Reprod Biomed Online. 2013;26(4):323–36. https://doi.org/10.1016/j.rbmo.2012.12.011.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Vercellini P., Viganò P., Somigliana E., Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–75. https://doi.org/10.1038/nren-do.2013.255.</mixed-citation><mixed-citation xml:lang="en">Vercellini P., Viganò P., Somigliana E., Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–75. https://doi.org/10.1038/nren-do.2013.255.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Giannella L., Carpini G.D., Sopracordevole F. et al. Atypical endometrial hyperplasia and unexpected cancers at final histology: a study on endometrial sampling methods and risk factors. Diagnostics (Basel). 2020;10(7):474. https://doi.org/10.3390/diagnostics10070474.</mixed-citation><mixed-citation xml:lang="en">Giannella L., Carpini G.D., Sopracordevole F. et al. Atypical endometrial hyperplasia and unexpected cancers at final histology: a study on endometrial sampling methods and risk factors. Diagnostics (Basel). 2020;10(7):474. https://doi.org/10.3390/diagnostics10070474.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Shan M., Carlson K.E., Bujotzek A.et al. Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor. ACS Chem Biol. 2013;8(4):707–15. https://doi.org/10.1021/cb3006243.</mixed-citation><mixed-citation xml:lang="en">Shan M., Carlson K.E., Bujotzek A.et al. Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor. ACS Chem Biol. 2013;8(4):707–15. https://doi.org/10.1021/cb3006243.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Wise L.A., Radin R.G., Kumanyika S.K. et al Prospective study of dietary fat and risk of uterine leiomyomata. Am J ClinNutr. 2014;99(5):1105–16. https://doi.org/10.3945/ajcn.113.073635.</mixed-citation><mixed-citation xml:lang="en">Wise L.A., Radin R.G., Kumanyika S.K. et al Prospective study of dietary fat and risk of uterine leiomyomata. Am J ClinNutr. 2014;99(5):1105–16. https://doi.org/10.3945/ajcn.113.073635.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Bakour S., Gupta J., Khan K. Risk factors associated with endometrial polyps in abnormal uterine bleeding. Int J Gynaecol Obstet. 2002;76(2):165–8. https://doi.org/10.1016/s0020-7292(01)00548-3.</mixed-citation><mixed-citation xml:lang="en">Bakour  S.,  Gupta  J.,  Khan  K.  Risk  factors  associated  with  endometrial polyps  in  abnormal  uterine  bleeding.  Int  J  Gynaecol  Obstet.  2002;76(2):165–8. https://doi.org/10.1016/s0020-7292(01)00548-3.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ismail S.M. Pathology of endometrium treated with tamoxifen. J Clin Pathol. 1994;47(9):827–33. https://doi.org/10.1136/jcp.47.9.827.</mixed-citation><mixed-citation xml:lang="en">Ismail S.M. Pathology of endometrium treated with tamoxifen. J Clin Pathol. 1994;47(9):827–33. https://doi.org/10.1136/jcp.47.9.827.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Saccardi C., Gizzo S., Patrelli T.S. et al. Endometrial surveillance in tamoxifen users: role, timing and accuracy of hysteroscopic investigation: observational longitudinal cohort study. Endocr Relat Cancer. 2013;20(4):455–62. https://doi.org/10.1530/erc-13-0020.</mixed-citation><mixed-citation xml:lang="en">Saccardi C., Gizzo S., Patrelli T.S. et al. Endometrial surveillance in tamoxifen users: role, timing and accuracy of hysteroscopic investigation: observational longitudinal cohort study. Endocr Relat Cancer. 2013;20(4):455–62. https://doi.org/10.1530/erc-13-0020.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Dibi R.P., Zettler C.G., Pessini S.A. et al. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer. Menopause. 2009;16(2):293–300. https://doi.org/10.1097/gme.0b013e31818af10a.</mixed-citation><mixed-citation xml:lang="en">Dibi R.P., Zettler C.G., Pessini S.A. et al. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer. Menopause. 2009;16(2):293–300. https://doi.org/10.1097/gme.0b013e31818af10a.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">American Association of Gynecologic Laparoscopists. AAGL practice report: practice guidelines for the diagnosis and management of endometrial polyps. J Minim Invasive Gynecol. 2012;19(1):3–10. https://doi.org/10.1016/j.jmig.2011.09.003.</mixed-citation><mixed-citation xml:lang="en">American Association of Gynecologic Laparoscopists. AAGL practice report: practice guidelines for the diagnosis and management of endometrial polyps. J Minim Invasive Gynecol. 2012;19(1):3–10. https://doi.org/10.1016/j.jmig.2011.09.003.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Nordengren J., Pilka R., Noskova V. et al. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle. Mol Hum Reprod. 2004;10(9):655–63. https://doi.org/10.1093/molehr/gah081.</mixed-citation><mixed-citation xml:lang="en">Nordengren J., Pilka R., Noskova V. et al. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle. Mol Hum Reprod. 2004;10(9):655–63. https://doi.org/10.1093/molehr/gah081.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">WHO Classification of Tumours of Female Reproductive Organs. Eds. R.J. Kurman, M.L. Carcangiu, C.S. Herrington, R.H. Young. WHO Classification of Tumours, 4th Edition. Lyon: International Agency for Research on Cancer, 2014. 307 p.</mixed-citation><mixed-citation xml:lang="en">WHO Classification of Tumours of Female Reproductive Organs. Eds. R.J. Kurman, M.L. Carcangiu, C.S. Herrington, R.H. Young. WHO Classification of Tumours, 4th Edition. Lyon: International Agency for Research on Cancer, 2014. 307 p.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Mulac-Jericevic B., Mullinax R.A., DeMayo F.J. et al. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science. 2000;289(5485):1751–4. https://doi.org/10.1126/science.289.5485.1751.</mixed-citation><mixed-citation xml:lang="en">Mulac-Jericevic B., Mullinax R.A., DeMayo F.J. et al. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science. 2000;289(5485):1751–4. https://doi.org/10.1126/science.289.5485.1751.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Grimm S.L., Hartig S.M., Edwards D.P. Progesterone receptor signaling mechanisms. J Mol Biol. 2016;428(19):3831–49. https://doi.org/10.1016/j.jmb.2016.06.020.</mixed-citation><mixed-citation xml:lang="en">Grimm S.L., Hartig S.M., Edwards D.P. Progesterone receptor signaling mechanisms. J Mol Biol. 2016;428(19):3831–49. https://doi.org/10.1016/j.jmb.2016.06.020.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Rojas P.A., May M., Sequeira G.R. et al. Progesterone receptor isoform ratio: a breast cancer prognostic and predictive factor for antiprogestin responsiveness. J Natl Cancer Inst. 2017;109(7):djw317. https://doi.org/10.1093/jnci/djw317.</mixed-citation><mixed-citation xml:lang="en">Rojas P.A., May M., Sequeira G.R. et al. Progesterone receptor isoform ratio: a breast cancer prognostic and predictive factor for antiprogestin responsiveness. J Natl Cancer Inst. 2017;109(7):djw317. https://doi.org/10.1093/jnci/djw317.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Miyamoto T., Watanabe J., Hata H. et al. Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma. J Steroid Biochem Mol Biol. 2004;92(3):111–8. https://doi.org/10.1016/j.jsbmb.2004.07.007.</mixed-citation><mixed-citation xml:lang="en">Miyamoto T., Watanabe J., Hata H. et al. Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma. J Steroid Biochem Mol Biol. 2004;92(3):111–8. https://doi.org/10.1016/j.jsbmb.2004.07.007.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Han A.R., Lee T.H., Kim S., Lee H.Y. Risk factors and biomarkers for the recurrence of ovarian endometrioma: about the immunoreactivity of progesterone receptor isoform B and nuclear factor kappa B. Gynecol Endocrinol. 2017;33(1):70–4. https://doi.org/10.1080/09513590.2016.1205580.</mixed-citation><mixed-citation xml:lang="en">Han A.R., Lee T.H., Kim S., Lee H.Y. Risk factors and biomarkers for the recurrence of ovarian endometrioma: about the immunoreactivity of progesterone receptor isoform B and nuclear factor kappa B. Gynecol Endocrinol. 2017;33(1):70–4. https://doi.org/10.1080/09513590.2016.1205580.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Kaya H.S., Hantak A.M., Stubbs L.J. et al. Roles of progesterone receptor A and B isoforms during human endometrial decidualization. Mol Endocrinol. 2015;29(6):882–95. https://doi.org/10.1210/me.2014-1363.</mixed-citation><mixed-citation xml:lang="en">Kaya H.S., Hantak A.M., Stubbs L.J. et al. Roles of progesterone receptor A and B isoforms during  human  endometrial  decidualization.  Mol  Endocrinol.  2015;29(6):882–95. https://doi.org/10.1210/me.2014-1363.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Mylonas I., Jeschke U., Shabani N. et al. Steroid receptors ERalpha, ERbeta, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium. Histol Histopathol. 2007;22(2):169–76. https://doi.org/10.14670/hh-22.169.</mixed-citation><mixed-citation xml:lang="en">Mylonas I., Jeschke U., Shabani N. et al. Steroid receptors ERalpha, ERbeta, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium. Histol Histopathol. 2007;22(2):169–76. https://doi.org/10.14670/hh-22.169.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Ryan A.J., Susil B., Jobling T.W., Oehler M.K. Endometrial cancer. Cell Tissue Res. 2002;322(1):53–61. https://doi.org/10.1007/s00441-005-1109-5.</mixed-citation><mixed-citation xml:lang="en">Ryan A.J., Susil B., Jobling T.W., Oehler M.K. Endometrial cancer. Cell Tissue Res. 2002;322(1):53–61. https://doi.org/10.1007/s00441-005-1109-5.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Аракелов С.Э., Прудникова Н.Ю., Ордияцн И.М., Жилина Н.В. Роль иммунореактивности и лизосомальных гидролаз АСЕ и GLU в эндометриии и плазме крови при рецидивированиигиперластических процессов энндометрия у женьщин в пре и постменопаузальном периоде. Вестник Российского университета дружбы народов. Серия Медицина. 2008;(6):149–58.</mixed-citation><mixed-citation xml:lang="en">Arakelov S.E., Prudnikova N.Yu., Ordiyatsn I.M., Zhilina N.V. The role of immunoreactivity and lysosomal hydrolases ACE and GLU in the endometrium and blood plasma during the recurrence of endometrial hyperplastic processes in pre- and postmenopausal women. [Rol' immunoreaktivnosti i lizosomal'nyh gidrolaz ASE i GLU v endometriii i plazme krovi pri recidivirovaniigiperlasticheskih processov enndometriya u zhen'shchin v pre i postmenopauzal'nom periode]. Vestnik Rossijskogo universiteta druzhby narodov. Seriya Medicina. 2008;(6):149–58. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Полина М.Л., Аракелов С.Э., Радзинский В.Е., Ордиянц И.М. Генетические детерминанты гинекологических и маммологических заболеваний у женщин репродуктивного возраста. Вестник Российского университета дружбы народов. Серия Медицина. 2008;(5):250–60.</mixed-citation><mixed-citation xml:lang="en">Polina M.L., Arakelov S.E., Radzinskiy V.E., Ordiyants I.M. Genetic determinants of gynecological and mammological diseases in women of reproductive age. [Geneticheskie determinanty ginekologicheskih i mammologicheskih zabolevanij u zhenshchin reproduktivnogo vozrasta]. Vestnik Rossijskogo universiteta druzhby narodov. Seriya Medicina. 2008;(5):250–60. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Zitao L., Kuokkanen S., Pal L. Steroid hormone receptor profile of premenopausal endometrial polyps. Reprod Sci. 2010;17(4):377–83. https://doi.org/10.1177/1933719109356803.</mixed-citation><mixed-citation xml:lang="en">Zitao L., Kuokkanen S., Pal L. Steroid hormone receptor profile of premenopausal endometrial polyps. Reprod Sci. 2010;17(4):377–83. https://doi.org/10.1177/1933719109356803.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Antunes A., Vassallo J., Pinheiro A. et al. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps: A comparison between benign and malignant polyps in postmenopausal patients. Oncol Lett. 2014;7(6):1944–50. https://doi.org/10.3892/ol.2014.2004.</mixed-citation><mixed-citation xml:lang="en">Antunes A., Vassallo J., Pinheiro A. et al. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps: A comparison between benign and malignant polyps in postmenopausal patients. Oncol Lett. 2014;7(6):1944–50. https://doi.org/10.3892/ol.2014.2004.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Giordano G., Gnetti L., Merisio C., Melpignano M. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Maturitas. 2007;56(2):190–7. https://doi.org/10.1016/j.maturitas.2006.08.002</mixed-citation><mixed-citation xml:lang="en">Giordano G., Gnetti L., Merisio C., Melpignano M. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Maturitas. 2007;56(2):190–7. https://doi.org/10.1016/j.maturitas.2006.08.002</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Topcu H.O., Erkaya S., Guzel A.I. et al. Risk factors for endometrial hyperplasia concomitant endometrial polyps in pre- and post-menopausal women. Asian Pac J Cancer Prev. 2014;15(13):5423–5. https://doi.org/10.7314/apjcp.2014.15.13.5423.</mixed-citation><mixed-citation xml:lang="en">Topcu H.O., Erkaya S., Guzel A.I. et al. Risk factors for endometrial hyperplasia concomitant endometrial polyps in pre- and post-menopausal women. Asian Pac J Cancer Prev. 2014;15(13):5423–5. https://doi.org/10.7314/apjcp.2014.15.13.5423.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Costa-Paiva L., Godoy C.E., Antunes A. et al. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinico-pathologic characteristics. Menopause. 2011;18(12):1278–82. https://doi.org/10.1097/gme.0b013e.31821e23a1.</mixed-citation><mixed-citation xml:lang="en">Costa-Paiva L., Godoy C.E., Antunes A. et al. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinico-pathologic characteristics. Menopause. 2011;18(12):1278–82. https://doi.org/10.1097/gme.0b013e.31821e23a1.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Коган Е.А., Станоевич И.В., Кудрина Е.А., Ищенко А.И. Морфологические и иммуногистохимическе параллели при гиперплазиях эндометрия. Архив патологии. 2007;(6):21–4.</mixed-citation><mixed-citation xml:lang="en">Kogan E.A., Stanoevich I.V., Kudrina E.A., Ishchenko A.I. Morphological and immunohistochemical  parallels  in  endometrial  hyperplasia.  [Morfologicheskie  i immunogistohimicheske paralleli pri giperplaziyah endometriya]. Arhiv patologii. 2007;(6):21–4. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Ахметова Е.С., Белокриницкая Т.Е., Витковский Ю.А. Воспалительные цитокины при диспластических процессах эндометрия. Материалы 9-го Всероссийского научного форума «Мать и дитя». М., 2007. 328–9.</mixed-citation><mixed-citation xml:lang="en">Akhmetova E.S., Belokrinitskaya T.E., Vitkovsky Yu.A. Inflammatory cytokines in endometrial dysplastic processes. [Vospalitel'nye citokiny pri displasticheskih processah endometri. Materialy 9-go Vserossijskogo nauchnogo foruma «Mat' i ditya»]. Moscow, 2007. 328–9. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Ищенко А.И., Кудрина Е.А., Станоевич И.В. Доброкачественные заболевания матки: социальные аспекты проблемы. Врач. 2008;(8):14–6.</mixed-citation><mixed-citation xml:lang="en">Ishchenko A.I., Kudrina E.A., Stanoevich I.V. Benign uterine diseases: social aspects of the problem. [Dobrokachestvennye zabolevaniya matki: social'nye aspekty problem]. Vrach. 2008;(8):14–6. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Bzhalava D., Muhr L.S., Lagheden C. et al. Deep sequencing extends the diversity of human papillomaviruses in human skin. Sci Rep. 2014;4:5807. https://doi.org/10.1038/srep05807.</mixed-citation><mixed-citation xml:lang="en">Bzhalava D., Muhr L.S., Lagheden C. et al. Deep sequencing extends the diversity of human papillomaviruses in human skin. Sci Rep. 2014;4:5807. https://doi.org/10.1038/srep05807.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Nagai Y. Persistence of human papillomavirus infection after therapeutic conization for CIN III: is it an alarm for disease recurrence? Gynecol Oncol. 2000;79(2):294–9. https://doi.org/10.1006/gyno.2000.5952.</mixed-citation><mixed-citation xml:lang="en">Nagai Y. Persistence of human papillomavirus infection after therapeutic conization for CIN III: is  it  an  alarm  for  disease  recurrence?  Gynecol  Oncol.  2000;79(2):294–9. https://doi.org/10.1006/gyno.2000.5952.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Бреусенко В.Г., Савельева Г.М., Голова Ю.А., Мишиева О.И. Лечение гиперпластических процессов эндометрия в периоде постменопаузы. Акушерство и гинекология. 2009;(4):19–23.</mixed-citation><mixed-citation xml:lang="en">Breusenko V.G., Savelyeva G.M., Golova Yu.A., Mishieva O.I. Treatment of endometrial hyperplastic processes in the postmenopausal period. [Lechenie giperplasticheskih processov endometriya v periode postmenopauzy]. Akusherstvo i ginekologiya. 2009;(4):19–23. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Саламова К.К., Сапрыкина Л.В., Рамазанова А.М. и др. Клинические особенности пациенток с гиперпластическими процессами эндометрия. РМЖ. Мать и дитя. 2021;4(2):124–9. DOI:10.32364/2618-8430-2021-4-2-124-129.</mixed-citation><mixed-citation xml:lang="en">Salamova K.K., Saprykina L.V., Ramazanova A.M. et al. Clinical characteristics of women with endometrial hyperplasia. [Klinicheskie osobennosti pacientok s giperplasticheskimi processami endometriya]. RMZh. Mat' i ditya. 2021;4(2):124–9. (In Russ.). DOI: 10.32364/2618-8430-2021-4-2-124-129.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Кондриков Н.И., Баринова И.В. Патология матки. Руководство для врачей. М.: Практическая медицина, 2019. 352 c.</mixed-citation><mixed-citation xml:lang="en">Kondrikov N.I., Barinova I.V. Uterine pathology. Guide for physicians. [Patologiya matki. Rukovodstvo dlya vrachej]. Moscow: Prakticheskaya medicina, 2019. 352 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Pathology and genetics of tumours of the breast and female genital organs. Eds. F.A. Tavassoli, P. Devilee. WHO classification of tumours, 3rd edition. Lyon: IARC Press, 2003. 432 р. https://doi.org/10.1111/j.1365-2559.2004.02026.x.</mixed-citation><mixed-citation xml:lang="en">Pathology and genetics of tumours of the breast and female genital organs. Eds. F.A. Tavassoli, P. Devilee. WHO classification of tumours, 3rd edition. Lyon: IARC Press, 2003. 432 р. https://doi.org/10.1111/j.1365-2559.2004.02026.x.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Пушкарев В.А., Мустафина Г.Т., Хуснутдинов Ш.М., Мазитов И.М. Полипы эндометрия (диагностика, клиника, лечение). Креативная хирургия и онкология. 2010;(1):43–8.</mixed-citation><mixed-citation xml:lang="en">Pushkarev V.A., Mustafina G.T., Khusnutdinov S.M., Mazitov I.M. Endometrial polyps (diagnosis, clinic, treatment). [Polipy endometriya (diagnostika, klinika, lechenie)]. Kreativnaya hirurgiya i onkologiya. 2010;(1):43–8. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Ярин Г.Ю., Люфт E.В., Вильгельми И.А. Опыт дифференцированного подхода к хирургическому лечению полипов эндометрия. Сибирское медицинское обозрение. 2020;(1):78–83. https://doi.org/10.20333/2500136-2020-1-78-83.</mixed-citation><mixed-citation xml:lang="en">Yarin G.Yu., Luft E.V., Wilhelmi I.A. Experience of a differentiated approach to surgical treatment of endometrial polyps. [Opyt differencirovannogo podhoda k hirurgicheskomu lecheniyu polipov  endometriya].  Sibirskoe  medicinskoe  obozrenie.  2020;(1):78–83.  (In  Russ.). https://doi.org/10.20333/2500136-2020-1-78-83.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">The American College of Obstetricians and Gynecologists Committee Opinion no. 631. Endometrial intraepithelial neoplasia. Obstet Gynecol. 2015;125(5):1272–8. https://doi.org/10.1097/01.AOG.0000465189.50026.20.</mixed-citation><mixed-citation xml:lang="en">The American College of Obstetricians and Gynecologists Committee Opinion no. 631. Endometrial  intraepithelial  neoplasia.  Obstet  Gynecol.  2015;125(5):1272–8. https://doi.org/10.1097/01.AOG.0000465189.50026.20.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Ma T., Readman E., Hicks L. et al. Is outpatient hysteroscopy the new gold standard? Results from an 11year prospective observational study. Aust N Z J Obstet Gynaecol. 2017;57(1):7480. https://doi.org/10.1111/ajo.12560.</mixed-citation><mixed-citation xml:lang="en">Ma T., Readman E., Hicks L. et al. Is outpatient hysteroscopy the new gold standard? Results from an 11year prospective observational study. Aust N Z J Obstet Gynaecol. 2017;57(1):7480. https://doi.org/10.1111/ajo.12560.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Елгина С.И., Золоторевская О.С., Бурова О.С. и др. Офисная гистероскопия в амбулаторной практике врача акушера-гинеколога. Мать и дитя в Кузбассе. 2018;(4):21–4.</mixed-citation><mixed-citation xml:lang="en">Elgina S.I., Zolotorevskaya O.S., Burova O.S. et al. Office hysteroscopy in the outpatient practice of an obstetrician-gynecologist. [Ofisnaya gisteroskopiya v ambulatornoj praktike vracha akushera-ginekologa]. Mat' i ditya v Kuzbasse. 2018;(4):21–4. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Саркисов С.Э., Хитрых О.В., Куковенко Е.М. Отдаленные результаты и оптимизация тактики лечения полипов эндометрия в постменопаузе. Акушерство и гинекология. 2009;(5):44–8.</mixed-citation><mixed-citation xml:lang="en">Sarkisov S.E., Khitrykh O.V., Kukovenko E.M. Long-term results and optimization of treatment tactics for endometrial polyps in postmenopause. [Otdalennye rezul'taty i optimizaciya taktiki lecheniya polipov endometriya v postmenopauze]. Akusherstvo i ginekologiya. 2009;(5):44–8. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Venturella R., Miele G., Cefalì K. et al. Subcutaneous progesterone for endometrial polyps in premenopausal women: a preliminary retrospective analysis. J Minim Invasive Gynecol. 2019;26(1):143–7. https://doi.org/10.1016/j.jmig.2018.04.023.</mixed-citation><mixed-citation xml:lang="en">Venturella R., Miele G., Cefalì K. et al. Subcutaneous progesterone for endometrial polyps in premenopausal women: a preliminary retrospective analysis. J Minim Invasive Gynecol. 2019;26(1):143–7. https://doi.org/10.1016/j.jmig.2018.04.023.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Kanthi J.M., Remadevi C., Sumathy S. et al. Clinical study of endometrial polyp and role of diagnostic hysteroscopy and blind avulsion of polyp. J Clin Diagn Res. 2016;10(6):QC01-4. https://doi.org/10.7860/JCDR/2016/18173.7983.</mixed-citation><mixed-citation xml:lang="en">Kanthi J.M., Remadevi C., Sumathy S. et al. Clinical study of endometrial polyp and role of diagnostic hysteroscopy and blind avulsion of polyp. J Clin Diagn Res. 2016;10(6):QC01-4. https://doi.org/10.7860/JCDR/2016/18173.7983.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">AlHilli M.M., Nixon K.E., Hopkins M.R. et al. Long-term out comes after intrauterine morcellation vs hysteroscopic resection of endometrial polyps. J Minim Invasive Gynecol. 2013;20(2):215–21. https://doi.org/10.1016/j.jmig.2012.10.013.</mixed-citation><mixed-citation xml:lang="en">AlHilli M.M., Nixon K.E., Hopkins M.R. et al. Long-term out comes after intrauterine morcellation vs hysteroscopic resection of endometrial polyps. J Minim Invasive Gynecol. 2013;20(2):215–21. https://doi.org/10.1016/j.jmig.2012.10.013.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Gao W., Zhang L., Li W. et al. Three-year follow-up results of polypectomy with endometrial ablation in the management of endometrial polyps associated with tamoxifen in Chinese women. Eur J Obstet Gynecol Reprod Biol. 2012;161(1):62–5. https://doi.org/10.1016/j.ejogrb.2011.10.014.</mixed-citation><mixed-citation xml:lang="en">Gao W., Zhang L., Li W. et al. Three-year follow-up results of polypectomy with endometrial ablation in the management of endometrial polyps associated with tamoxifen in Chinese women. Eur J Obstet Gynecol Reprod Biol. 2012;161(1):62–5. https://doi.org/10.1016/j.ejogrb.2011.10.014.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
